Turn Biotechnologies Acquires Innovative ARMMs Technology Enhancing Access to Tissue Targets for Advanced Epigenetic Therapies Turn Biotechnologies enhances its capabilities with the acquisition of ARMMs technology, improving the efficiency of its epigenetic therapies targeting various tissues for personalized medicine.

Turn Biotechnologies Acquires Innovative ARMMs Technology Enhancing Access to Tissue Targets for Advanced Epigenetic Therapies #USA #Mountain_View #Turn_Biotechnologies #ARMMs_Technology #Epigenetic_Therapy

Turn Biotechnologies Enhances Epigenetic Therapy with ARMMs Technology Acquisition Turn Biotechnologies announces the acquisition of ARMMs vesicular technology, enhancing their precision medicine capabilities for epigenetic therapies.

Turn Biotechnologies Enhances Epigenetic Therapy with ARMMs Technology Acquisition #USA #Mountain_View #Turn_Biotechnologies #ARMMs_Technology #Epigenetic_Therapy

Turn Biotechnologies' Game-Changing Acquisition of ARMMs Technology Boosts Precision Epigenetic Therapies In a significant move, Turn Biotechnologies acquires ARMMs technology to enhance the precision and effectiveness of its epigenetic therapies.

Turn Biotechnologies' Game-Changing Acquisition of ARMMs Technology Boosts Precision Epigenetic Therapies #United_States #Mountain_View #Turn_Biotechnologies #ARMMs_Technology #Epigenetic_Therapy